Compare Direxion Daily CSI China Internet Bull 2X Shares (CWEB) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily CSI China Internet Bull 2X Shares vs Tempus AI — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.91 (market cap $173.62M), while Tempus AI trades at $70.93 (market cap $12.58B). The key difference: Tempus AI is far larger — about 72.5× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and Tempus AI is trading nearer its 52-week high, Direxion Daily CSI China Internet Bull 2X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and Tempus AI for 23 Days on average.
| CWEB | TEM | |
|---|---|---|
Market Cap | $173.62M | $12.58B |
Volume | 551,726 | 7,444,569 |
Sector | Leveraged / Inverse | Broad Market / Factor |
52-Week High | $55.62 | $99.28 |
52-Week Low | $17.39 | $41.55 |
Typical Hold Time | 24 Days | 23 Days |
Enterprise Value | — | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CWEB trades at $18.91, up 4.94% today, but technical indicators show a bearish trend with moving averages and ADX signaling sell conditions. The stock faces resistance at $18 with support at $17. Recent news highlights China's AI sector growth potential as a catalyst for CWEB's performance.
Outlook remains cautious due to bearish technicals, though exposure to China's AI and semiconductor sectors offers growth opportunities. Key risks include geopolitical tensions and market volatility. Investors should monitor earnings reports for fundamental validation of current valuation levels.
Tempus AI (TEM) trades at $70.93, up 0.91% today, with a bullish technical signal and strong analyst support. The stock shows robust revenue growth, with 2026 revenue reaching $1.4B, but remains unprofitable with a net margin of -17.77%. Recent FDA clearance for its ECG-MR AI product and positive ESMO Congress abstracts highlight innovation momentum, though negative cash flow from operations and insider selling pose concerns.
Outlook is cautiously optimistic given 64% buy ratings and a $72.60 consensus target, but profitability challenges and high valuation multiples (P/S 8.61, P/B 28.27) demand scrutiny. Key risks include sustained losses, competitive pressures, and reliance on financing activities for liquidity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Direxion Daily CSI China Internet Bull 2X Shares
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
